Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Guthrie

Showing results (181-190 of 197) with videos related to

Pageof 20
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 8, 2018
Hypocitraturia Is an Untoward Side Effect of Synthetic Human Parathyroid Hormone (hPTH) 1-34 Therapy in Hypoparathyroidism That May Increase Renal MorbidityRachel I Gafni, Craig B Langman, Lori C Guthrie, et al.
Pilot and Feasibility Studies|September 28, 2021
Randomized trial of the feasibility of ED-initiated school-based asthma medication supervision (ED-SAMS)Lynn B Gerald, Joe K Gerald, John M VanBuren, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 19, 2018
Scoliosis in Fibrous Dysplasia/McCune-Albright Syndrome: Factors Associated With Curve Progression and Effects of BisphosphonatesJason A Berglund, Sri Harsha Tella, Kaitlyn F Tuthill, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 21, 2015
Transient Increased Calcium and Calcitriol Requirements After Discontinuation of Human Synthetic Parathyroid Hormone 1-34 (hPTH 1-34) Replacement Therapy in HypoparathyroidismRachel I Gafni, Lori C Guthrie, Marilyn H Kelly, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 16, 2019
Age-Related Changes and Effects of Bisphosphonates on Bone Turnover and Disease Progression in Fibrous Dysplasia of BonePablo Florenzano, Kristen S Pan, Sydney M Brown, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutationsMichael T Collins, Nicholas J Sarlis, Maria J Merino, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 31, 2018
Tumor-induced osteomalacia in association with PTEN-negative Cowden syndromeJ A Berglund, R I Gafni, F Wodajo, et al.
Orphanet Journal of Rare Diseases|May 1, 2019
Gynecologic and reproductive outcomes in fibrous dysplasia/McCune-Albright syndromeAlison M Boyce, Rachel K Casey, Diana Ovejero Crespo, et al.
The Journal of Clinical Investigation|September 19, 2018
Autoimmune hyperphosphatemic tumoral calcinosis in a patient with FGF23 autoantibodiesMary Scott Roberts, Peter D Burbelo, Daniela Egli-Spichtig, et al.
Journal of Surgical Oncology|December 26, 2002
Role of metastasectomy in the management of thyroid carcinoma: the NIH experienceHo Pak, Loukas Gourgiotis, Wen-I Chang, et al.
Pageof 20

Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 8, 2018
Hypocitraturia Is an Untoward Side Effect of Synthetic Human Parathyroid Hormone (hPTH) 1-34 Therapy in Hypoparathyroidism That May Increase Renal MorbidityRachel I Gafni, Craig B Langman, Lori C Guthrie, et al.
Pilot and Feasibility Studies|September 28, 2021
Randomized trial of the feasibility of ED-initiated school-based asthma medication supervision (ED-SAMS)Lynn B Gerald, Joe K Gerald, John M VanBuren, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|April 19, 2018
Scoliosis in Fibrous Dysplasia/McCune-Albright Syndrome: Factors Associated With Curve Progression and Effects of BisphosphonatesJason A Berglund, Sri Harsha Tella, Kaitlyn F Tuthill, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 21, 2015
Transient Increased Calcium and Calcitriol Requirements After Discontinuation of Human Synthetic Parathyroid Hormone 1-34 (hPTH 1-34) Replacement Therapy in HypoparathyroidismRachel I Gafni, Lori C Guthrie, Marilyn H Kelly, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 16, 2019
Age-Related Changes and Effects of Bisphosphonates on Bone Turnover and Disease Progression in Fibrous Dysplasia of BonePablo Florenzano, Kristen S Pan, Sydney M Brown, et al.
The Journal of Clinical Endocrinology and Metabolism|September 13, 2003
Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutationsMichael T Collins, Nicholas J Sarlis, Maria J Merino, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 31, 2018
Tumor-induced osteomalacia in association with PTEN-negative Cowden syndromeJ A Berglund, R I Gafni, F Wodajo, et al.
Orphanet Journal of Rare Diseases|May 1, 2019
Gynecologic and reproductive outcomes in fibrous dysplasia/McCune-Albright syndromeAlison M Boyce, Rachel K Casey, Diana Ovejero Crespo, et al.
The Journal of Clinical Investigation|September 19, 2018
Autoimmune hyperphosphatemic tumoral calcinosis in a patient with FGF23 autoantibodiesMary Scott Roberts, Peter D Burbelo, Daniela Egli-Spichtig, et al.
Journal of Surgical Oncology|December 26, 2002
Role of metastasectomy in the management of thyroid carcinoma: the NIH experienceHo Pak, Loukas Gourgiotis, Wen-I Chang, et al.
Pageof 20